Biogena Group Invest AG

WBO:BIO (Austria)   Ordinary Shares
€ 2.06 (-3.74%) May 27
47.91
P/B:
0.97
Market Cap:
€ 8.22M ($ 8.93M)
Enterprise V:
€ 8.20M ($ 8.90M)
Volume:
3.00K
Avg Vol (2M):
2.33K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Biogena Group Invest AG ( WBO:BIO ) from 2020 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biogena Group Invest AG stock (WBO:BIO) PE ratio as of May 28 2024 is 47.91. More Details

Biogena Group Invest AG (WBO:BIO) PE Ratio (TTM) Chart

To

Biogena Group Invest AG (WBO:BIO) PE Ratio (TTM) Historical Data

Total 853
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
Biogena Group Invest AG PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-28 47.9 2024-03-21 48.8
2024-05-27 47.9 2024-03-20 51.2
2024-05-24 49.8 2024-03-19 44.6
2024-05-23 48.4 2024-03-18 36.7
2024-05-22 48.4 2024-03-15 36.7
2024-05-21 48.4 2024-03-14 36.7
2024-05-20 47.9 2024-03-13 36.7
2024-05-17 47.0 2024-03-12 36.7
2024-05-16 45.4 2024-03-11 35.6
2024-05-15 46.5 2024-03-08 35.6
2024-05-14 48.4 2024-03-07 36.0
2024-05-13 50.2 2024-03-06 37.4
2024-05-10 50.2 2024-03-05 36.7
2024-05-09 50.2 2024-03-04 38.6
2024-05-08 50.2 2024-03-01 38.1
2024-05-07 50.2 2024-02-29 39.8
2024-05-06 50.2 2024-02-28 39.8
2024-05-03 50.2 2024-02-27 39.8
2024-05-02 50.2 2024-02-26 39.8
2024-04-30 50.2 2024-02-23 39.8
2024-04-29 51.6 2024-02-22 40.0
2024-04-26 50.7 2024-02-21 40.5
2024-04-25 50.7 2024-02-20 40.5
2024-04-24 51.6 2024-02-19 40.5
2024-04-23 51.6 2024-02-16 38.6
2024-04-22 51.6 2024-02-15 41.4
2024-04-19 51.6 2024-02-14 40.7
2024-04-18 53.0 2024-02-13 41.6
2024-04-17 54.9 2024-02-12 41.6
2024-04-16 47.4 2024-02-09 40.9
2024-04-15 49.8 2024-02-08 42.6
2024-04-12 48.8 2024-02-07 42.6
2024-04-11 48.8 2024-02-06 43.3
2024-04-10 49.8 2024-02-05 43.0
2024-04-09 51.6 2024-02-02 42.8
2024-04-08 45.8 2024-02-01 43.3
2024-04-05 47.9 2024-01-31 43.3
2024-04-04 47.9 2024-01-30 43.5
2024-04-03 49.8 2024-01-29 43.5
2024-04-02 49.8 2024-01-26 25.9
2024-03-28 47.9 2024-01-25 24.9
2024-03-27 48.8 2024-01-24 24.9
2024-03-26 47.9 2024-01-23 24.9
2024-03-25 47.9 2024-01-22 24.7
2024-03-22 53.5 2024-01-19 24.0

Biogena Group Invest AG (WBO:BIO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Biogena Group Invest AG

ISIN : ATBIOGENA005

Share Class Description:

WBO:BIO: Ordinary Shares
Description
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.